Depomed Reports First Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. ZS
2. MRVL
3. PENG
4. STZ
5. CRBU
6. SKYD
7. BBIO
8. OPCH
9. NEOG
10. HALO

Go back to Depomed Reports First Quarter 2015 Financial Results

DepoMed (DEPO) Sell-Off an 'Over-Reaction', Roth Capital Says; PT to $28.50

May 12, 2015 12:42 PM EDT

Roth Capital analyst Scott Henry trimmed his price target on DepoMed Inc (NASDAQ: DEPO) to $28.50 (from $30.00) following Q1 results but maintained a Buy rating. The firm views today's 18% sell-off as a "over-reaction."

Henry commented, "DEPO reported 1Q15 results that were at the lower end... More

DepoMed (DEPO) Misses Q1 EPS by 14c; Guides FY15 Sales Above Views

May 11, 2015 4:15 PM EDT

DepoMed (NASDAQ: DEPO) reported Q1 EPS of ($0.13), $0.14 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $31.7 million versus the consensus estimate of $33.8 million.

DepoMed sees FY2015 revenue of $310-335 million, versus the consensus of $305.02 million.

For earnings history and earnings-related data on DepoMed (DEPO) click here.

... More